When minutes matter
For people with critical illnesses or injuries, access to effective treatment is imperative. Often taking place in an emergency or intensive care setting, critical care can be complex, fast paced and involve a wide variety of conditions and treatment plans.
Our research program supports critical care through clinical trials and other studies to improve patient outcomes and advance medicine. Our studies address the continuum of care from emergency to discharge and beyond. And since the pandemic began, we have engaged in high-impact studies of drugs and treatments for COVID-19.
Through our Critical Care Research Center, we oversee clinical research in these specialty areas:
- Emergency medical services
- Emergency medicine department
- Surgical intensive care unit
- Medical intensive care unit
- COVID-19 treatment
- Burn and Wound Care Center
- Level I Adult and Pediatric Trauma Centers
- Hospital medicine department
- Cardiology and heart research
- General surgery
Our clinician investigators are leading studies in traumatic brain injury, cardiac arrest resuscitation, septic shock, heart research, COVID-19 treatment, pain and more.
COVID-19 clinical trials
Early in the pandemic, we developed processes to quickly and safely initiate studies that explored possible treatments for all stages of COVID-19. These studies not only bolstered hope, they improved patient care. Our researchers have looked at the effectiveness of several therapies including convalescent plasma, monoclonal antibodies, and drugs that moderate the body’s inflammatory response to infection. We continue to manage a portfolio of COVID-19 clinical trials—remaining nimble and committed as we evaluate new and existing treatments.